(JNS.org) The Israeli company Mazor Robotics Ltd. will unveil its new Renaissance Guidance System brain module at the American Association of Neurological Surgeons (AANS) annual meeting in San Francisco next week.
The brain module, which has been approved by the U.S. Food and Drug Administration (FDA) for both spine and brain surgery, offers accurate surgical access to areas of the brain.
Using a small platform with three fixation points, the module minimizes the need for incisions and resulting scars. At the same time, physicians have 360 degrees of working volume and can more easily change trajectory during surgery.
“We are very happy to see the benefits that Renaissance Brain Surgery is bringing to neurosurgeons and their patients,” said Mazor Robotics CEO Ori Hadomi, according to Globes. “After years of development, we are excited to introduce our technology to the brain surgery market and continue our efforts in this new arena."
So far, the system has been used to place 45,000 implants during thousands of spine procedures around the world.